CAS 21238-30-2
:(2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,11E,13E,16R)-4-(acetyloxy)-5-methoxy-9,16-dimethyl-2,10-dioxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl]oxy}-4-hydroxy-2,4-dimeth
Description:
The chemical substance with the name "(2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,11E,13E,16R)-4-(acetyloxy)-5-methoxy-9,16-dimethyl-2,10-dioxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl]oxy}-4-hydroxy-2,4-dimeth" and CAS number "21238-30-2" is a complex organic molecule characterized by multiple stereocenters and functional groups. It features a polycyclic structure, which includes a dioxo moiety and various substituents such as acetyloxy, methoxy, and dimethylamino groups. The presence of multiple hydroxyl groups indicates potential for hydrogen bonding, which may influence its solubility and reactivity. This compound likely exhibits biological activity, as suggested by its intricate structure, which may interact with biological targets. Its stereochemistry is crucial for its function, as the specific arrangement of atoms can significantly affect its pharmacological properties. Overall, this substance represents a sophisticated example of organic chemistry with potential applications in medicinal chemistry or related fields.
Formula:C42H67NO15
InChI:InChI=1/C42H67NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29,31,34-41,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1
Synonyms:- 21238-30-2
- 9-Deoxy-9-oxoleucomycin V 3-Acetate 4B-(3-Methylbutanoate)
- Carbomycin B
- Magnamycin B
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Carbomycin B
CAS:Carbomycin B, a precursor in making Carbomycin, is a macrolite antibiotic from Stroptomyces halstedii, akin to Leucomycin and Erythromycin.Formula:C42H67NO15Purity:98%Color and Shape:SolidMolecular weight:825.99Magnamycin B (>80%)
CAS:Controlled Product<p>Applications Magnamycin B is an intermediate in the synthesis of Carbomycin (C176680), an macrolite antibiotic complex similar to Leucomycin and Erythromycin, produced by Stroptomyces halstedii.<br>References Zhou, Y., et al.: Bioorg. Med. Chem. Lett., 17, 1206 (2007),<br></p>Formula:C42H67NO15Purity:>80%Color and Shape:NeatMolecular weight:825.98Magnamycin B
CAS:<p>Magnamycin B is an antifungal antibiotic, which is derived from natural sources through microbial fermentation. Its mode of action involves the inhibition of cell wall synthesis in pathogenic fungi, thereby disrupting essential processes required for their growth and proliferation. Magnamycin B is particularly effective against a range of fungal pathogens that affect agricultural and clinical settings.</p>Formula:C42H67NO15Purity:Min. 95%Molecular weight:826.00 g/mol


